<span item_type="fundamental" item_id="b3974c63f4c66125f7f16ea4026d9d51" counter_id="ST/US/ALUR" env="prod"></span><span item_type="announcement" item_id="604183901468756481" env="prod"></span><p>Revenue: As of FY2025, the actual value is USD 15 M, beating the estimate of USD 14.55 M.</p><p></p><h3>Revenue</h3><ul><li>Fourth quarter revenue is estimated to be between $3.3 million and $3.7 million, representing a 22% to 37% increase quarter-over-quarter. The full-year revenue is approximately $15 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-ex99_1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>There is a substantial improvement in operating expenses and operating loss both quarter-over-quarter and compared to the prior year.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-ex99_1.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>The company anticipates a more efficient 2026 due to a strategic focus and potential FDA approval of the Allurion Smart Capsule, which could make 2026 a historic year for Allurion.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-ex99_1.htm"></span></li></ul>

Allurion Tech | 8-K: FY2025 Revenue Beats Estimate at USD 15 M